Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Barker

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Diabetes Care|March 25, 2011
Additional autoimmune disease found in 33% of patients at type 1 diabetes onsetTaylor M Triolo, Taylor K Armstrong, Kim McFann, et al.
Diabetes Care|May 27, 2004
Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-upJennifer M Barker, Stephanie H Goehrig, Katherine Barriga, et al.
Pediatric Pulmonology|September 9, 2011
Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximabJonathan Popler, Mohammad Alimohammadi, Olle Kämpe, et al.
Diabetes|August 13, 2008
Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screeningJennifer M Barker, Taylor M Triolo, Theresa A Aly, et al.
Diabetes Care|March 29, 2005
Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groupsJennifer M Barker, Jeesuk Yu, Liping Yu, et al.
Clinical Immunology (Orlando, Fla.)|September 11, 2007
A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1Li Zhang, Jennifer M Barker, Sunanda Babu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetesTaylor M Triolo, Erin E Baschal, Taylor K Armstrong, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2011
Dominant suppression of Addison's disease associated with HLA-B15Peter R Baker, Erin E Baschal, Pam R Fain, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2010
Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's diseasePeter R Baker, Erin E Baschal, Pam R Fain, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2022
Hepatic abnormalities in youth with Turner syndromeIsani Singh, Gillian Noel, Jennifer M Barker, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Diabetes Care|March 25, 2011
Additional autoimmune disease found in 33% of patients at type 1 diabetes onsetTaylor M Triolo, Taylor K Armstrong, Kim McFann, et al.
Diabetes Care|May 27, 2004
Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-upJennifer M Barker, Stephanie H Goehrig, Katherine Barriga, et al.
Pediatric Pulmonology|September 9, 2011
Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximabJonathan Popler, Mohammad Alimohammadi, Olle Kämpe, et al.
Diabetes|August 13, 2008
Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screeningJennifer M Barker, Taylor M Triolo, Theresa A Aly, et al.
Diabetes Care|March 29, 2005
Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groupsJennifer M Barker, Jeesuk Yu, Liping Yu, et al.
Clinical Immunology (Orlando, Fla.)|September 11, 2007
A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1Li Zhang, Jennifer M Barker, Sunanda Babu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetesTaylor M Triolo, Erin E Baschal, Taylor K Armstrong, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2011
Dominant suppression of Addison's disease associated with HLA-B15Peter R Baker, Erin E Baschal, Pam R Fain, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2010
Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's diseasePeter R Baker, Erin E Baschal, Pam R Fain, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2022
Hepatic abnormalities in youth with Turner syndromeIsani Singh, Gillian Noel, Jennifer M Barker, et al.
Pageof 5